Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)

Ambee Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 5, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	1,812	1,960	1,829	1,318	1,260	985
Market Cap Growth	-0.88%	7.12%	38.81%	4.57%	27.92%	-14.60%
Enterprise Value	2,369	2,445	2,240	1,629	1,521	1,202
Last Close Price	754.90	815.42	760.13	546.57	521.71	407.85
PE Ratio	274.33	369.08	188.91	144.98	156.37	-
PS Ratio	9.87	8.50	8.34	6.65	6.96	9.95
PB Ratio	52.68	60.61	62.17	56.46	23.92	21.97
P/TBV Ratio	52.68	60.61	62.17	56.46	23.92	21.97
P/OCF Ratio	89.49	90.16	-	-	-	-
EV/Sales Ratio	12.90	10.61	10.22	8.22	8.40	12.14
EV/EBITDA Ratio	186.27	196.29	122.73	80.79	77.41	-
EV/EBIT Ratio	-	330.94	180.50	123.64	102.35	-
Debt / Equity Ratio	19.20	19.76	0.03	16.82	6.55	5.35
Debt / EBITDA Ratio	51.93	49.53	0.05	18.95	16.49	-
Net Debt / Equity Ratio	16.19	15.66	-1.08	15.59	6.22	5.01
Net Debt / EBITDA Ratio	45.38	40.65	-1.75	18.05	16.70	-134.45
Net Debt / FCF Ratio	106.05	-245.76	0.47	-10.30	-4.39	-41.23
Asset Turnover	0.25	0.35	0.40	0.39	0.39	0.23
Inventory Turnover	0.39	0.55	0.49	0.49	0.54	0.40
Quick Ratio	0.44	0.47	0.38	0.34	0.29	0.29
Current Ratio	0.84	0.83	0.91	0.88	0.92	0.87
Return on Equity (ROE)	20.45%	17.19%	36.70%	23.91%	16.53%	-25.34%
Return on Assets (ROA)	0.44%	0.70%	1.41%	1.62%	2.01%	-1.07%
Return on Invested Capital (ROIC)	0.67%	2.00%	5.28%	2.92%	3.60%	-2.68%
Return on Capital Employed (ROCE)	13.80%	20.30%	36.30%	44.70%	24.80%	-13.70%
Earnings Yield	0.36%	0.27%	0.53%	0.69%	0.64%	-1.32%
FCF Yield	0.29%	-0.10%	-3.72%	-2.68%	-5.93%	-0.55%
Dividend Yield	0.13%	0.12%	0.13%	0.27%	0.19%	-
Payout Ratio	32.37%	44.23%	34.91%	11.00%	18.61%	-
Total Shareholder Return	0.13%	0.12%	0.13%	0.27%	0.19%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.